Lab Sciences
Top stories summarized by our editors
9/15/2017

Health officials have placed a temporary hold on blood donations from residents in parts of Rome after 17 people were diagnosed with chikungunya virus infection. The affected area includes 1.2 million residents, and people who have visited since Aug. 25 are being asked to wait 28 days before donating.

Full Story:
Reuters
9/15/2017

A study in the journal Clinical Infectious Diseases found that patients who survive Ebola virus infections remain challenged by health issues such as limited mobility, vision and cognition in the following year. Researchers from the Liverpool School of Tropical Medicine followed 27 Ebola survivors and 54 close contacts in Sierra Leone.

9/15/2017

Five cases of Serratia marcescens bloodstream infection were reported at the University of Wisconsin Hospital in Madison in 2014. An investigation concluded that opioid solutions had been removed from pre-filled syringes and replaced with a saline solution contaminated with Serratia.

9/14/2017

A project dubbed "Tissue Chip for Disease Modeling and Efficacy Testing" of the National Center for Advancing Translational Sciences received $15 million in funding from the NIH to advance the development of 3D human tissue models. The research will produce 3D tissue chips that will allow scientists to test the efficacy of potential drugs through models that simulate the biological functions of organs and tissues.

More Summaries:
NIH
9/14/2017

Women of reproductive age who had hepatitis C showed signs of ovarian senescence, increasing their risk of infertility, gestational diabetes and miscarriage, compared with women who had hepatitis B or those without liver disease, researchers reported in the Journal of Hepatology. Achieving a sustained virologic response to antiviral therapy may reduce the risk of miscarriage, researchers found.

More Summaries:
liver disease, HCV
9/14/2017

Hyundai Hope on Wheels has awarded a total of $400,000 in grants to two Johns Hopkins researchers studying pediatric cancer. Dr. Brian Ladle will study the combination of immunotherapy and chemotherapy for osteosarcoma patients, while Dr. Kenneth Cooke will look for ways to improve bone marrow transplant outcomes.

Full Story:
WMAR-TV (Baltimore)
More Summaries:
Hyundai, Johns Hopkins, bone marrow
9/14/2017

Researchers surveyed 200 hemodialysis patients about their preferences for anemia treatment and found patients were willing to accept 1.7 transfusions or a 4.5% risk of heart attack from medications or pay an additional $94 in order to increase symptom relief from 25% to 75%. The study in the journal BMC Nephrology also found that patients on average valued going from two to one transfusions per month more than going from one to zero transfusions per month.

9/14/2017

The Irish Blood Transfusion Service is testing an information technology solution involving name and gender changes for transgender donors after a transgender woman requested that her information be changed in the system. "Because a donor's gender will have an impact on how donated blood is used for patients, changing that gender may have safety implication for recipients," so the IT change must be "fully explored to ensure there are no unintended consequences," the transfusion service said.

More Summaries:
information technology
9/14/2017

Researchers reviewed 3,800 scientific articles and determined that genetic evidence has been found for the presence of 27 infectious viruses -- including Zika, Ebola and chikungunya -- in human semen, according to a report in the journal Emerging Infectious Diseases. The study authors noted that the presence of a virus does not mean it can necessarily be transmitted sexually.

Full Story:
HealthDay News
More Summaries:
Zika
9/13/2017

A research partnership among several colleges and universities in Georgia has been awarded a $20 million grant from the National Science Foundation to study ways cells can be used to treat such conditions as cancer and heart disease. The grant will go toward a new research center based at the Georgia Institute of Technology, which is leading the partnership.